Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,198 $ 12,360
Short-term investments 22,336 17,327
Receivables 334 47
Prepaid expenses and other current assets 532 466
Total current assets 26,400 30,200
Operating lease right-of-use asset 178 212
Total assets 26,578 30,412
Current liabilities:    
Accounts payable 94 265
Accrued expenses 1,712 1,726
Operating lease liability 51 46
Total current liabilities 1,857 2,037
Operating lease liability, non-current 136 175
Total liabilities 1,993 2,212
Commitments and contingencies (Note 10)
Shareholders’ equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 31,017,770 and 30,913,902 shares issued and outstanding as of July 31, 2023 and October 31, 2022, respectively 310 309
Additional paid-in capital 250,716 247,123
Accumulated deficit (225,506) (218,385)
Total shareholders’ equity 25,520 29,047
Noncontrolling interest (Note 2) (935) (847)
Total equity 24,585 28,200
Total liabilities and equity 26,578 30,412
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, value